Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: The prostate, 82.2021, 1, S. 120-131
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Universitätsbibliothek Johann Christian Senckenberg
- (wann)
-
2021
- Urheber
-
Höh, Robert Benedikt
Würnschimmel, Christoph
Flammia, Rocco Simone
Horlemann, Benedikt
Sorce, Gabriele
Chierigo, Francesco
Tian, Zhe
Saad, Fred
Graefen, Markus
Gallucci, Michele
Briganti, Alberto
Terrone, Carlo
Shariat, Shahrokh F.
Kluth, Luis
Mandel, Philipp
Chun, Felix
Karakiewicz, Pierre I.
- DOI
-
10.1002/pros.24253
- URN
-
urn:nbn:de:hebis:30:3-745481
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Höh, Robert Benedikt
- Würnschimmel, Christoph
- Flammia, Rocco Simone
- Horlemann, Benedikt
- Sorce, Gabriele
- Chierigo, Francesco
- Tian, Zhe
- Saad, Fred
- Graefen, Markus
- Gallucci, Michele
- Briganti, Alberto
- Terrone, Carlo
- Shariat, Shahrokh F.
- Kluth, Luis
- Mandel, Philipp
- Chun, Felix
- Karakiewicz, Pierre I.
- Universitätsbibliothek Johann Christian Senckenberg
Entstanden
- 2021
Ähnliche Objekte (12)
Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients
Understanding high-risk business
Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients
BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families
Focal therapy in intermediate- and high-risk prostate cancer
Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
CALN1 hypomethylation as a biomarker for high-risk bladder cancer
Capecitabine as Maintenance Therapy for High-Risk, Resected Colorectal Cancer
African KhoeSan ancestry linked to high-risk prostate cancer
Stereotacticbody radiotherapy for high-risk prostate cancer: a systematic review
Transport of the high-risk neonate
High-risk pregnancy and risk of breastfeeding failure
Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients
Understanding high-risk business
Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients
BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families
Focal therapy in intermediate- and high-risk prostate cancer
Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
CALN1 hypomethylation as a biomarker for high-risk bladder cancer
Capecitabine as Maintenance Therapy for High-Risk, Resected Colorectal Cancer
African KhoeSan ancestry linked to high-risk prostate cancer
Stereotacticbody radiotherapy for high-risk prostate cancer: a systematic review
Transport of the high-risk neonate
High-risk pregnancy and risk of breastfeeding failure
Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients
Understanding high-risk business
Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients
BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families
Focal therapy in intermediate- and high-risk prostate cancer
Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
CALN1 hypomethylation as a biomarker for high-risk bladder cancer
Capecitabine as Maintenance Therapy for High-Risk, Resected Colorectal Cancer
African KhoeSan ancestry linked to high-risk prostate cancer
Stereotacticbody radiotherapy for high-risk prostate cancer: a systematic review
Transport of the high-risk neonate